The Offer with a face value of ₹10 per Equity Share is a mix of fresh issue of Rs 1,125 crore and an offer ... May 10
Depression among the elderly is a pressing issue in today's age, exacerbated by factors such as social isolation, health challenges, and financial insecurities. However, ... Jul 11
Zyla Health intends to use the funds to strengthen its leadership and invest in integrating Zyla's care products across the ecosystem to expand. The ... Jul 07
In its Series C round, Varun Khanna’s Fullife Healthcare raised $22 million from Morgan Stanley Private Equity Asia or MSPEA. Read to find out ... Dec 15
If the right dosage of sleep keeps the body fit, then less dosage can spoil the health. As a result, diabetes, obesity, and other health ... Sep 27
Dynavax Technologies Corporation, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on ... Dec 11
Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease... Nov 23
The study shows how social determinants of health influence the time interval between breast imaging and follow-up appointments... Nov 19
Health Canada has cleared CytoDyn to file its Biologics License Application (BLA) for leronlimab as a combination therapy for multi-drug resistance HIV patients in ... Nov 16
Arbutus Biopharma Corporation a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus (HBV) infection as well ... Nov 16
BioXcel Therapeutics announced that it has completed its pre-NDA meeting with the FDA for BXCL501 for the acute treatment of agitation in patients with ... Nov 12
PDS Biotech and Farmacore today announced Updates on its co-development program for a Versamune®-based vaccine aimed at preventing COVID-19 infection.... Nov 11
BriaCell Announces Collaboration with the National Cancer Institute.... Nov 10
Novartis Cosentyx shows early synovitis reduction in patients with psoriatic arthritis in the first-of-its-kind study... Nov 05
Centogene, announced today the opening of its walk-in COVID-19 testing facility at the newly opened Berlin Brandenburg Airport (BER).... Nov 05
Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million... Oct 29
Novartis and Molecular Partners AG today announced a collaboration to develop two DARPin® therapies designed for potential use against COVID-19... Oct 28
Leronlimab Shows Early, but Promising Clinical Responses in First Two Patients Recovering from Stroke... Oct 27
MHRA of the U.K. government has cleared CytoDyn to file its Biologics License Application (BLA) for leronlimab as a combination therapy for multi-drug ... Oct 27
ViralClear Pharmaceuticals, Inc. announced the halting of its signal finding Phase 2 hospitalized Covid-19 trial.... Oct 27
Researchers will present new data supporting the Xoft System for the treatment of early-stage breast cancer and gynecological cancers.... Oct 24
Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer... Oct 24
ASLAN has now initiated recruitment into the third, highest dose (600mg) cohort of the randomised, double blind, placebo-controlled MAD study. ... Oct 22
Median OS of 13.3 months has been observed in the Phase I/IIa study for patients treated with Bria-IMTâ„¢ in combination with immune ... Oct 21
-Advertisements-
Saturday, June 01, 2024
.jpg)
